J9357 HCPCS code: Injection, valrubicin, intravesical, 200 mg
J9357 is the HCPCS Level II code for injection, valrubicin, intravesical, 200 mg. In 2024 Medicare paid an average of $1,084.51 per service for J9357 across 1,310 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 4 per day on outpatient hospital claims. Medicare volume fell 34% from 2022 to 2024 (1,986 to 1,310 services). In 2024, about 95 clinicians billed Medicare for J9357 for 73 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2000-01-01 |
| Last action effective | 2009-01-01 |
Who bills J9357 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 95 |
| Medicare beneficiaries | 73 |
| States with claims | 1 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9357, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 1,986 | 107 | $1,375.05 | $1,096.46 |
| 2023 | 1,308 | 71 | $1,386.35 | $1,103.76 |
| 2024 | 1,310 | 73 | $1,362.75 | $1,084.51 |
States with the most J9357 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| North Carolina | 236 | $1,084.44 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 4 | Prescribing Information |
| practitioner claims | 4 | Prescribing Information |
What changed for J9357
- 2000-01-01: J9357 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9357?
J9357 is the HCPCS Level II code for injection, valrubicin, intravesical, 200 mg. Short descriptor: "Valrubicin injection".
How much does Medicare pay for J9357?
In 2024, the average Medicare payment was $1,084.51 per service (average allowed $1,362.75).
Does Medicare cover J9357?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
How many units of J9357 can be billed per day?
4 on outpatient hospital claims; 4 on practitioner claims (NCCI medically unlikely edits).
Related J93 codes
- J9300 — Injection, gemtuzumab ozogamicin, 5 mg
- J9301 — Injection, obinutuzumab, 10 mg
- J9302 — Injection, ofatumumab, 10 mg
- J9303 — Injection, panitumumab, 10 mg
- J9304 — Injection, pemetrexed (pemfexy), 10 mg
- J9305 — Injection, pemetrexed, not otherwise specified, 10 mg
- J9306 — Injection, pertuzumab, 1 mg
- J9307 — Injection, pralatrexate, 1 mg
- J9308 — Injection, ramucirumab, 5 mg
- J9309 — Injection, polatuzumab vedotin-piiq, 1 mg
- J9310 — Injection, rituximab, 100 mg
- J9311 — Injection, rituximab 10 mg and hyaluronidase
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9357
- Watch J9357 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9357
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.